Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Operating Margin

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at SurModics

is 33.41%. SurModics' ROE for the same period is 10.12%. The trailing-twelve-month operating margin at Meridian Bioscience

is 29.72%. Meridian Bioscience's profit margin for the same period is 19.72%. The trailing-twelve-month operating margin at Trinity Biotech plc

is 20.91%. Trinity Biotech's revenue for the same period is $82.51 million. The trailing-twelve-month operating margin at Abaxis

is 12.49%. Abaxis had $70.07 million in total cash for the latest quarter.